Skip to main content

Stress Echocardiography

  • Chapter
  • First Online:
  • 1587 Accesses

Abstract

Heart failure is a progressive, lethal syndrome characterized by accelerating deterioration. Its estimated prevalence in the United States is around 2.0%, with an increased prevalence of 6–10% in patients >65 years old. The prognosis of heart failure is uniformly poor if the underlying problem cannot be rectified; half of all patients carrying a diagnosis of heart failure will die within 4 years, and in patients with severe heart failure more than 50% will die within 1 year. The actual rate of deterioration is highly variable and depends on the nature and causes of the overload, the age of the patient, and many other factors (Fig. 10.1).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Swedberg K, Cleland J, Dargie H, et al.; Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-40

    Google Scholar 

  2. Hunt SA, Abraham WT, Chin MH, et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-235.

    Google Scholar 

  3. Katz AM. Heart Failure. Pathophysiology, Molecular Biology and Clinical Management. Philadelphia: Lippincott Williams and Wilkins; 2001.

    Google Scholar 

  4. Henein MY, Cailes J, O’Sullivan C, et al. Abnormal ventricular long-axis function in systemic sclerosis. Chest. 1995;108:1533-1540.

    Article  PubMed  CAS  Google Scholar 

  5. Fang ZY, Najos-Valencia O, Leano R, et al. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol. 2003;42:446-453.

    Article  PubMed  CAS  Google Scholar 

  6. Kobayashi T, Tamano K, Takahashi M, et al. Myocardial systolic function of the left ventricle along the long axis in patients with essential hypertension: a study by pulsed tissue Doppler imaging. J Cardiol. 2003;41:175-182.

    PubMed  Google Scholar 

  7. Klewer SE, Goldberg SJ, Donnerstein RL, et al. Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol. 1992;19:394-401.

    Article  PubMed  CAS  Google Scholar 

  8. Mariotti E, Agostini A, Angelucci E, et al. Reduced left ventricular contractile reserve identified by low dose dobutamine echocardiography as an early marker of cardiac involvement in asymptomatic patients with thalassemia major. Echocardiography. 1996;13:463-472.

    Article  PubMed  Google Scholar 

  9. Ha JW, Lee HC, Kang ES, et al. Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart. 2007;93:1571-1576.

    Article  PubMed  Google Scholar 

  10. Kawano S, Ilda K, Fujeda K, et al. Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy. J Am Coll Cardiol. 1995;25:687-692.

    Article  PubMed  CAS  Google Scholar 

  11. Picano E. Diabetic cardiomyopathy. The importance of being earliest. J Am Coll Cardiol. 2003;42:454-457.

    Article  PubMed  Google Scholar 

  12. Neglia D, Parodi O, Gallopin M, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation. 1995;92:796-804.

    Article  PubMed  CAS  Google Scholar 

  13. Montisci R, Vacca A, Garau P, et al. Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Ann Rheum Dis. 2003;62:890-893.

    Article  PubMed  CAS  Google Scholar 

  14. Galderisi M, Capaldo B, Sidiropulos M, et al. Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis. Am J Hypertens. 2007;20:1283-1290.

    Article  PubMed  Google Scholar 

  15. Bartel T, Yang Y, Müller S, et al. Noninvasive assessment of microvascular function in arterial hypertension by transthoracic Doppler harmonic echocardiography. J Am Coll Cardiol. 2002;39:2012-2018.

    Article  PubMed  Google Scholar 

  16. Agricola E, Oppizzi M, Pisani M, et al. Stress echocardiography in heart failure. Cardiovasc Ultrasound. 2004;2:11.

    Article  PubMed  Google Scholar 

  17. Neskovic AN, Otasevic P. Stress-echocardiography in idiopathic dilated cardiomyopathy: instructions for use. Cardiovasc Ultrasound. 2005;3:3.

    Article  PubMed  Google Scholar 

  18. Nagaoka H, Isobe N, Kubota S, et al. Myocardial contractile reserve as prognostic determinant in patients with idiopathic dilated cardiomyopathy without overt heart failure. Chest. 1997;111:344-350.

    Article  PubMed  CAS  Google Scholar 

  19. Paelinck B, Vermeersch P, Stockman D, et al. Usefulness of low-dose dobutamine stress echocardiography in predicting recovery of poor left ventricular function in atrial fibrillation dilated cardiomyopathy. Am J Cardiol. 1999;83:1668-1671.

    Article  PubMed  CAS  Google Scholar 

  20. Naqvi TZ, Goel RK, Forrester JS, et al. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1999;34:1537-1544.

    Article  PubMed  CAS  Google Scholar 

  21. Kitaoka H, Takata J, Yabe T, et al. Dobutamine stress echocardiography can predict the improvement of left ventricular systolic function in dilated cardiomyopathy. Heart. 1999;81:523-527.

    PubMed  CAS  Google Scholar 

  22. Scrutinio D, Napoli V, Passantino A, et al. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Eur Heart J. 2000;21:927-934.

    Article  PubMed  CAS  Google Scholar 

  23. Paraskevaidis IA, Adamopoulos S, Kremastinos DT. Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. J Am Coll Cardiol. 2001;37:1685-1691.

    Article  PubMed  CAS  Google Scholar 

  24. Pratali L, Picano E, Otasevic P, et al. Prognostic significance of dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol. 2001;88:1374-1378.

    Article  PubMed  CAS  Google Scholar 

  25. Pinamonti B, Perkan A, Di Lenarda A, et al. Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur J Heart Fail. 2002;4:49-61.

    Article  PubMed  Google Scholar 

  26. Drozdz J, Krzeminska-Pakula M, Plewka M, et al. Prognostic value of low-dose dobutamine echocardiography in patients with idiopathic dilated cardiomyopathy. Chest. 2002;121:1216-1222.

    Article  PubMed  Google Scholar 

  27. Otasevic P, Popovic ZB, Vasiljevic JD, et al. Head-to-head comparison of indices of left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in idiopathic dilated cardiomyopathy: five-year follow up. Heart. 2006;92:1253-1258.

    Article  PubMed  CAS  Google Scholar 

  28. Williams MJ, Odabashian J, Lauer MS, et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 1996;27:132-139.

    Article  PubMed  CAS  Google Scholar 

  29. Marron A, Schneeweiss A. Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol. 1997;29:422-428.

    Article  Google Scholar 

  30. Pratali L, Otasevic P, Rigo F, et al. The additive prognostic value of restrictive pattern and dipyridamole-induced contractile reserve in idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2005;7:844-851.

    Article  PubMed  CAS  Google Scholar 

  31. Pratali L, Otasevic P, Neskovic A, et al. DIP Prognostic value of pharmacologic stress echocardiography in patients with idiopathic dilated cardiomyopathy: a prospective, head-to-head comparison between dipyridamole and dobutamine test. J Card Fail. 2007;13:836-842.

    Article  PubMed  Google Scholar 

  32. Rigo F, Gherardi S, Galderisi M, et al. The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy. Eur Heart J. 2006;27:1319-1323.

    Article  PubMed  Google Scholar 

  33. Rigo F, Richieri M, Pasanisi E, et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol. 2003;91:269-273.

    Article  PubMed  Google Scholar 

  34. Pinamonti B, Zecchin M, Di Lenarda A, et al. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol. 1997;29:604-612.

    Article  PubMed  CAS  Google Scholar 

  35. Frassi F, Gargani L, Tesorio P, et al. Prognostic value of extravascular lung water assessed with ultrasound lung comets by chest sonography in patients with dyspnea and/or chest pain. J Card Fail. 2007;13:830-835.

    Article  PubMed  Google Scholar 

  36. Sharp SM, Sawada SG, Segar DS, et al. Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol. 1994;24:934-939.

    Article  PubMed  CAS  Google Scholar 

  37. Vigna C, Russo A, De Rito V, et al. Regional wall motion analysis by dobutamine stress echocardiography to distinguish between ischemic and non-ischemic dilated cardiomyopathy. Am Heart J. 1996;131:537-543.

    Article  PubMed  CAS  Google Scholar 

  38. Cohen A, Chauvel C, Benhalima B, et al. Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy? Angiology. 1997;48:783-793.

    Article  PubMed  CAS  Google Scholar 

  39. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158.

    Article  PubMed  Google Scholar 

  40. Galderisi M, Cattaneo F, Mondillo S. Doppler echocardiography and myocardial dyssynchrony: a practical update of old and new ultrasound technologies. Cardiovasc Ultrasound. 2007;5:28.

    Article  PubMed  Google Scholar 

  41. Gorcsan J III, Abraham T, Agler DA, et al.; American Society of Echocardiography Dyssynchrony Writing Group. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr. 2008;21:191-213.

    Google Scholar 

  42. Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;2008(117):2608-2616.

    Article  Google Scholar 

  43. Da Costa A, Thévenin J, Roche F, et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm. 2006;3:406-413.

    Article  PubMed  Google Scholar 

  44. Ciampi Q, Pratali L, Citro R, et al (2009) Identification of responders to CRT by stress echo: no contractile reserve, no party. Eur J Heart Failure. 2009;11:489-496.

    Google Scholar 

  45. Jourdain P, Funck F, Fulla Y, et al. Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol. Eur J Heart Fail. 2002;4:269-276.

    Article  PubMed  CAS  Google Scholar 

  46. Schwammenthal E, Vered Z, Moshkowitz Y, et al. Dobutamine echocardiography in patients with aortic stenosis and left ventricular dysfunction: predicting outcome as a function of management strategy. Chest. 2001;119:1766-1777.

    Article  PubMed  CAS  Google Scholar 

  47. Ciampi Q, Villari B. Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. Cardiovasc Ultrasound. 2007;5:34.

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

Reproduced from Picano E, Stress echocardiography, Fifth edition, Springer, Berlin, 2009.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eugenio Picano .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer London

About this chapter

Cite this chapter

Picano, E. (2010). Stress Echocardiography. In: Henein, M. (eds) Heart Failure in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84996-153-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-153-0_10

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-152-3

  • Online ISBN: 978-1-84996-153-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics